Stay updated on Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record for nivolumab in relapsed or refractory peripheral T-cell lymphoma is displayed instead of an access-denied error. It includes study details and results, eligibility criteria, and a study protocol document.
    Difference
    62%
    Check dated 2026-11-08T05:15:58.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision displayed in the footer changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T02:18:47.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says “Super Intelligence” will replace “Artificial Intelligence” in agency content during the transition.
    Difference
    1%
    Check dated 2026-10-25T02:23:39.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page; its footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T02:00:22.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T03:09:01.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now displayed, replacing the study record content. The site header and footer remain visible, signaling an access/permission issue rather than a substantive study data update.
    Difference
    20%
    Check dated 2026-09-20T01:09:53.000Z thumbnail image

Stay in the know with updates to Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.